Your browser doesn't support javascript.
loading
In drug-refractory IBS, group CBT with interoceptive exposure improved symptoms and QoL at 13 wk.
Oliver, Daniel; Talley, Nicholas J.
Afiliación
  • Oliver D; University of Newcastle and John Hunter Hospital, Newcastle, New South Wales, Australia (D.O., N.J.T.).
  • Talley NJ; University of Newcastle and John Hunter Hospital, Newcastle, New South Wales, Australia (D.O., N.J.T.).
Ann Intern Med ; 175(8): JC90, 2022 08.
Article en En | MEDLINE | ID: mdl-35914262
SOURCE CITATION: Kikuchi S, Oe Y, Ito Y, et al. Group cognitive-behavioral therapy with interoceptive exposure for drug-refractory irritable bowel syndrome: a randomized controlled trial. Am J Gastroenterol. 2022;117:668-77. 35103022.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Terapia Cognitivo-Conductual / Síndrome del Colon Irritable Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: Ann Intern Med Año: 2022 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Terapia Cognitivo-Conductual / Síndrome del Colon Irritable Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Humans Idioma: En Revista: Ann Intern Med Año: 2022 Tipo del documento: Article